⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Quaero Life Science Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Quaero Life Science Co., Ltd.
↗Jiaxing, China
Quaero Life Science is a prominent Contract Design and Manufacturing Organization (CDMO) serving the in-vitro diagnostic (IVD) and life science industries. The company provides fully automated, intelligent solutions, covering the entire product life cycle from design and R&D to precision manufacturing, registration, and after-sales maintenance.
With extensive engineering expertise in mechanical, fluid, optical, electronic, and software systems, Quaero operates three R&D centers in China (Jiaxing, Shanghai, and Hangzhou) and has expanded internationally with facilities in North America and Japan. They are a key partner for major IVD manufacturers, offering both specialized instrumentation and high-quality consumables through their subsidiary, Zhejiang Biorear Biotechnology.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:CDMO
Sub-Industry:IVD Instruments & Life Science Consumables
SIZE & FINANCIALS
Employees:501-1000
Founded:2005
Ownership:private
Status:operating
FUNDING
Stage:Pre-IPO
0
CORPORATE STRUCTURE
Subsidiaries:Zhejiang Biorear Biotechnology, Quaero Life Science North America, Inc.
Key Partnerships:Precision System Science Co., Ltd (PSS) - Joint venture for global CDMO market, Chemclin Diagnostics, TransGen Biotech, Autobio, AmoyDx
COMPETITION
Position:Leader
LINKS
Website:quaerolife.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Quaero Life Science Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.